Holen Sie sich die Stockscreener-App
4.72
1.07%
0.05
Handel nachbörslich:
4.99
0.27
+5.72%
Schlusskurs vom Vortag:
$4.67
Offen:
$4.7
24-Stunden-Volumen:
265.47K
Relative Volume:
0.45
Marktkapitalisierung:
$156.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-86.60M
KGV:
-1.6664
EPS:
-2.8324
Netto-Cashflow:
$-67.37M
1W Leistung:
-0.84%
1M Leistung:
+5.59%
6M Leistung:
+11.85%
1J Leistung:
-59.66%
1-Tages-Spanne:
$4.57
$4.9653
1-Wochen-Bereich:
$4.3418
$4.9653
52-Wochen-Spanne:
$1.45
$12.76
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
Firmenname
Lexeo Therapeutics Inc
Sektor
Branche
Telefon
(212) 547-9879
Adresse
345 PARK AVENUE SOUTH, NEW YORK
Vergleichen Sie LXEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
4.72 | 252.10M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2024-06-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-06-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-28 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-11-28 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-28 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Lexeo Therapeutics Inc Aktie (LXEO) Neueste Nachrichten
What makes Lexeo Therapeutics Inc. stock price move sharplyLow Float Short Squeeze Picks - thegnnews.com
Lexeo Therapeutics Inc. Matches Institutional Buying FilterBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru
Stifel Maintains Buy Rating on Lexeo Therapeutics (LXEO) - MSN
Lexeo Therapeutics Inc. Stock Approaches Key Moving AverageChart Breakout Buy Signal Detection Confirmed - beatles.ru
Traders Watching For Reversal Pattern in Lexeo Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
Oppenheimer Begins Coverage on Lexeo Therapeutics (NASDAQ:LXEO) - MarketBeat
How does Lexeo Therapeutics Inc. generate profit in a changing economyBuild wealth with reliable stock picks - Jammu Links News
How strong is Lexeo Therapeutics Inc. company’s balance sheetGet real-time updates on market trends - Jammu Links News
What is Lexeo Therapeutics Inc. company’s growth strategyFree Risk Assessment Services - Jammu Links News
Is it the right time to buy Lexeo Therapeutics Inc. stockAchieve consistent profits with expert advice - Jammu Links News
How many analysts rate Lexeo Therapeutics Inc. as a “Buy”Superior returns - Jammu Links News
Published on: 2025-08-04 05:32:29 - Jammu Links News
What are the technical indicators suggesting about Lexeo Therapeutics Inc.Consistent double returns - Jammu Links News
What are Lexeo Therapeutics Inc. company’s key revenue driversPhenomenal returns - Jammu Links News
How does Lexeo Therapeutics Inc. compare to its industry peersMaximize your gains with professional insights - Jammu Links News
What is the risk reward ratio of investing in Lexeo Therapeutics Inc. stockMaximize gains with professional stock picks - Jammu Links News
Is Lexeo Therapeutics Inc. a good long term investmentMarket-beating performance - Jammu Links News
What are analysts’ price targets for Lexeo Therapeutics Inc. in the next 12 monthsBuild a portfolio with strong long-term growth - Jammu Links News
Published on: 2025-08-03 06:15:28 - Jammu Links News
What is the dividend policy of Lexeo Therapeutics Inc. stockDynamic profit opportunities - Jammu Links News
How volatile is Lexeo Therapeutics Inc. stock compared to the marketDiscover market opportunities with real-time data - Jammu Links News
Lexeo Therapeutics Analyst Begins Coverage on Bullish Note; Top 3 Initiations for Thursday - AInvest
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga
Oppenheimer Initiates Lexeo Therapeutics(LXEO.US) With Buy Rating, Announces Target Price $20 - 富途牛牛
Lexeo Therapeutics Initiates Coverage: Oppenheimer Outperform Rating with $20 PT - AInvest
Lexeo Therapeutics shares rise 7.31% premarket after FDA grants breakthrough therapy designation to LX2006. - AInvest
Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating By Investing.com - Investing.com India
Oppenheimer initiates Lexeo Therapeutics stock with Outperform rating - Investing.com Australia
Should I hold or sell Lexeo Therapeutics Inc. stock in 2025Advanced Screener Ideas For Fast Growth - Jammu Links News
Stifel Reiterates Buy Rating for Lexeo Therapeutics with $21 Price Target Following FDA Breakthrough Therapy Designation for LX2006 - AInvest
Candlestick Reversal Detected on Lexeo Therapeutics Inc.’s ChartPotential Breakout Stock List Published This Week - metal.it
Lexeo Therapeutics' LX2006 Receives Breakthrough Therapy Designation from FDA, Shares Rise 17% - AInvest
Lexeo Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowGrowth Based Stock Signal Screener Updated - metal.it
11 Best New Penny Stocks to Buy Right Now - Insider Monkey
What does LXEO's flat EPS in 2024 suggest for investors? - AInvest
How did LXEO's operating expenses trend in Q4 2024? - AInvest
Does Lexeo Therapeutics Inc. stock perform well during market downturnsDiscover high-growth stocks for your portfolio - Jammu Links News
Will Lexeo Therapeutics Inc. stock split in the near futureFree Smart Money Stock Analysis - metal.it
When is Lexeo Therapeutics Inc. stock expected to show significant growthProven strategies for superior portfolio growth - jammulinksnews.com
Why is Lexeo Therapeutics Inc. stock attracting strong analyst attentionRapid-fire capital growth - Jammu Links News
Finanzdaten der Lexeo Therapeutics Inc-Aktie (LXEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):